NASDAQ

Sarepta Therapeutics, Inc. (SRPT)

♥ 569 Thanks from members

Live price chart, market sentiment, and community perspectives for Sarepta Therapeutics, Inc. (NASDAQ: SRPT).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: Health CareIndustry: BiotechnologyFounder: Kudus AlahmadFounder: Inovative Therapeutics TeamLeadership: Doug Ingram (CEO)Leadership: Louise Rodino-Klapac (Head of RandD)Holder: The Vanguard GroupHolder: BlackRock, Inc.Holder: Capital Research Global InvestorsExondys 51Vyondys 53Amondys 45Elevidys#SRPT stock#Sarepta Therapeutics#NASDAQ SRPT#Genetic Medicine#Duchenne Muscular Dystrophy